Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5080
Gene Symbol: PAX6
PAX6
0.350 Biomarker disease GENOMICS_ENGLAND
Entrez Id: 26060
Gene Symbol: APPL1
APPL1
0.330 Biomarker disease GENOMICS_ENGLAND
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.100 Biomarker disease BEFREE <b><i>Conclusions:</i> Oral health measured by number of tooth extractions >10 was an independent predictor for cerebral infarction in addition to age, HDL-C, hs-C-reactive protein and diabetes. 31814529 2019
Entrez Id: 388581
Gene Symbol: C1QTNF12
C1QTNF12
0.020 Biomarker disease BEFREE <b>Background:</b> Adipolin, the novel adipokine that is proposed to be reduced in diabetes, obesity and inflammation, may improve glycemic control. 27657997 2017
Entrez Id: 55829
Gene Symbol: SELENOS
SELENOS
0.040 AlteredExpression disease BEFREE <b>Background:</b> Selenoprotein S (SelS) gene expression is positively correlated to triglyceride (TG) concentrations and is associated with diabetes in animal model. 30413610 2018
Entrez Id: 114548
Gene Symbol: NLRP3
NLRP3
0.100 Biomarker disease BEFREE <b>Background:</b> The NLRP3 inflammasome is one of the key contributors to impaired wound healing in diabetes. 31736762 2019
Entrez Id: 197
Gene Symbol: AHSG
AHSG
0.100 AlteredExpression disease BEFREE <b>Conclusion:</b> Lower fetuin-A levels are associated with an increased risk of all-cause mortality independent of diabetes and inflammation in dialysis patients, and there may be a dose-response relationship between them. 31417425 2019
Entrez Id: 406983
Gene Symbol: MIR200A
MIR200A
0.010 Biomarker disease BEFREE <b>Conclusion:</b> miR-200a/200b are involved in modulating HG-induced endothelial inflammation by regulating OGT-mediated protein <i>O</i>-GlcNAcylation, suggesting the therapeutic role of miR-200a/200b on vascular complications in diabetes. 29720943 2018
Entrez Id: 49
Gene Symbol: ACR
ACR
0.050 Biomarker disease BEFREE <b>Conclusions</b>: Home urinalysis self-testing of ACR in people with diabetes is estimated to be a cost-effective use of NHS resources in England in people who would otherwise not comply with standard care. 31354065 2019
Entrez Id: 4810
Gene Symbol: NHS
NHS
0.100 Biomarker disease BEFREE <b>Conclusions</b>: Home urinalysis self-testing of ACR in people with diabetes is estimated to be a cost-effective use of NHS resources in England in people who would otherwise not comply with standard care. 31354065 2019
Entrez Id: 55908
Gene Symbol: ANGPTL8
ANGPTL8
0.100 Biomarker disease BEFREE <b>Conclusions:</b> In a group of subjects ranging from those with normal glucose tolerance to newly diagnosed diabetes, we found that 25(OH)D and fasting glucose were factors associated with serum betatrophin concentration. 26910534 2017
Entrez Id: 693203
Gene Symbol: MIR618
MIR618
0.010 AlteredExpression disease BEFREE <b>Conclusions:</b> In this cohort of type 1 diabetes individuals, serum miR-518d-3p and miR-618 were upregulated in those with diabetes kidney disease, diabetes retinopathy, peripheral neuropathy, and cardiovascular autonomic neuropathy in comparison to individuals with no microvascular complications. 31249556 2019
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.100 GeneticVariation disease BEFREE <b>Objective:</b> The association of interleukin-10 (IL-10) polymorphism with diabetes and its complication was recently established, while there were few researches considering the potential role of IL-10 in gestational diabetes (GDM). 30873205 2019
Entrez Id: 6720
Gene Symbol: SREBF1
SREBF1
0.060 Biomarker disease BEFREE <b>Results</b>: Both SREBPs mRNA expression were significantly higher in patients with CAD and diabetes (p<0.001) and were identified as independent cardiovascular risk factor for coronary artery disease in patients with type-2 diabetes (SREBP-1: OR 1.7, 95%CI 1.1-2.5, p=0.02; SREBP-2: OR 1.6, 95%CI 1.2-3, p=0.02) and were independently associated with the presence of multivessel CAD, left main and anterior descending artery stenosis, and higher total and LDL cholesterol levels, and lower HDL cholesterol levels, in patients with CAD and diabetes. 28367087 2017
Entrez Id: 6721
Gene Symbol: SREBF2
SREBF2
0.050 Biomarker disease BEFREE <b>Results</b>: Both SREBPs mRNA expression were significantly higher in patients with CAD and diabetes (p<0.001) and were identified as independent cardiovascular risk factor for coronary artery disease in patients with type-2 diabetes (SREBP-1: OR 1.7, 95%CI 1.1-2.5, p=0.02; SREBP-2: OR 1.6, 95%CI 1.2-3, p=0.02) and were independently associated with the presence of multivessel CAD, left main and anterior descending artery stenosis, and higher total and LDL cholesterol levels, and lower HDL cholesterol levels, in patients with CAD and diabetes. 28367087 2017
Entrez Id: 2695
Gene Symbol: GIP
GIP
0.100 Biomarker disease BEFREE <b>Results</b>: Recent literature shows that GLP-1 and its agonists, DPP-4 inhibitors and combined GLP-1/GIP molecules are effective in partially or fully reversing the effects of neurotoxic compounds, neurovascular complications of diabetes, neuropathological changes related with Alzheimer's disease, Parkinson's disease or vascular occlusion. 30938196 2019
Entrez Id: 2539
Gene Symbol: G6PD
G6PD
0.100 Biomarker disease BEFREE <b>Results:</b> A 40% reduction of risk for cancer of endodermal origin was observed among G6PD-deficient patients compared with subjects with normal enzyme activity (relative risk (RR) 0.61, 95% confidence interval (CI) 0.47-0.80) in both genders, confirmed by multivariable generalized linear regression after adjusting for age, sex, smoking habits, body mass index, diabetes and socio-economic status. 31109224 2019
Entrez Id: 6484
Gene Symbol: ST3GAL4
ST3GAL4
0.100 Biomarker disease BEFREE <b>Results:</b> Our results showed that CaD was capable of reducing albuminuria and restoring renal histological changes in KK-Ay and HFD/STZ-induced diabetic mice. 31447680 2019
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.070 Biomarker disease BEFREE <i>Akkermansia muciniphila</i> is potential probiotic in that its type strain ATCC BAA-835 has beneficial effects upon obesity and diabetes.However, whether <i>A. muciniphila</i> can improve inflammatory bowel diseases (IBD), which is a form of chronic intestinal dysbiosis, is unknown.Hence, we used an isolated murine <i>A. muciniphila</i> strain (designated 139) and <i>A. muciniphila</i> type strain ATCC, to investigate their anti-inflammatory properties in cell models and in Dextran Sulfate Sodium (DSS)-induced chronic colitis of mice.<i>In vitro</i>, the two <i>A. muciniphila</i> strains exerted similar anti-inflammatory properties as they both reduced IL-8 production by TNF-α-stimulated HT-29 cells. 31334133 2019
Entrez Id: 9056
Gene Symbol: SLC7A7
SLC7A7
0.010 Biomarker disease BEFREE <i>Mo</i>-LPI is a promising alternative or complementary agent to treat diabetes. 28208654 2017
Entrez Id: 6524
Gene Symbol: SLC5A2
SLC5A2
0.100 Biomarker disease BEFREE <i>Sglt1</i> (also known as <i>Slc5a1</i>) and <i>Sglt2</i> (also known as <i>Slc5a2</i>) knockout mice were employed to develop sotagliflozin, a dual SGLT1/SGLT2 inhibitor having success in clinical trials for diabetes. 31064765 2019
Entrez Id: 5054
Gene Symbol: SERPINE1
SERPINE1
0.100 AlteredExpression disease BEFREE (1) The plasma PAI-1 levels of group A (60.39 ± 17.01 ng/L), group B (68.76 ± 17.81 ng/L) and group C and (68.63 ± 18.30 ng/L) are higher than that of controls (46.26 ± 26.04 ng/L); (2) Patients with genotype 4G/4G tended to exhibit higher PAI-1 level; (3) The distribution frequency of genotype 4G/4G in group C was significantly higher than in group A (42.4% vs. 28.7%, p < 0.05) and (4) In type 2 diabetic patients, the occurrence of diabetes nephropathy in genotype 4G/4G, 4G/5G and 5G/5G is 35.0%, 30.2% and 21.4%, respectively. 26616527 2016
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.100 Biomarker disease BEFREE (2018) demonstrate that IL-6 infusion has GLP-1-dependent and -independent actions with opposing effects on glucose tolerance, resulting in an overall improvement in healthy male volunteers but no improvement in male patients with diabetes. 29874560 2018
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.100 Biomarker disease BEFREE (3) Diabetes and high fat diet, which lead to a significant increase in inflammatory molecules and cytokines, including MCP-1, which induces changes in podocyte cytoskeleton and nephrin loss. 19077682 2009
Entrez Id: 2597
Gene Symbol: GAPDH
GAPDH
0.010 Biomarker disease BEFREE (b) The second network demonstrates novel interactions between GAPDH and inflammatory and proliferation candidate genes i.e., SUMO4 and EGFR indicating a new link between obesity and diabetes. 19997558 2009